28.06.2016 Views

Neuropsychiatric Symptoms of Epilepsy

5qIFB7UWr

5qIFB7UWr

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chapter 14<br />

Dementia<br />

Alla Guekht<br />

Abstract Association between epilepsy and dementia has been described centuries<br />

ago; still many neurobiological, clinical, and therapeutic issues remain unclear. This<br />

comorbidity is currently in the focus <strong>of</strong> experimental, translational, and clinical<br />

research.<br />

There are similarities (as well as differences) between patients with dementias<br />

and those with temporal lobe epilepsy (TLE), and between animal models <strong>of</strong><br />

Alzheimer disease (AD) and TLE. Seizures in the human temporal lobe transiently<br />

impair cognition and steadily damage hippocampal circuitry, leading to progressive<br />

memory loss; many mechanisms involved in AD influence excitability and cause<br />

seizures.<br />

On one hand, there is a multifactorial cognitive deficit in patients with chronic<br />

epilepsy; it is driven by the impact <strong>of</strong> the underlying etiology, the effects <strong>of</strong> recurrent<br />

seizures, adverse effects <strong>of</strong> antiepileptic drugs (AEDs), and psychosocial<br />

issues.<br />

On the other hand, seizures are frequently observed in patients with dementia.<br />

The incidence <strong>of</strong> seizures among patients with dementia varies with the etiology <strong>of</strong><br />

the dementing illness.<br />

The proper choice <strong>of</strong> AEDs is essential in symptomatic treatment <strong>of</strong> seizures in<br />

patients with dementia; possible risks and benefits <strong>of</strong> the drug for the elderly patient<br />

should be noted.<br />

Better understanding <strong>of</strong> the converging neurobiological pathways <strong>of</strong> epilepsy<br />

and dementia could enrich the therapeutic armamentarium and allow improved control<br />

<strong>of</strong> both conditions, ameliorate related abnormalities and potentially modify disease<br />

progression.<br />

Keywords <strong>Epilepsy</strong> • Seizures • Cognitive decline • Alzheimer’s disease • Vascular<br />

dementia • Apolipoprotein E • β-amyloid • Hippocampal sclerosis • Excitotoxicity •<br />

Antiepileptic drugs<br />

A. Guekht , MD, PhD<br />

Department <strong>of</strong> Neurology, Neurosurgery and Genetics , Russian National Research Medical<br />

University and Moscow Research and Clinical Center for Neuropsychiatry , Donskaya, 43 ,<br />

Moscow 115419 , Russia<br />

e-mail: guekht@gmail.com<br />

© Springer International Publishing Switzerland 2016<br />

M. Mula (ed.), <strong>Neuropsychiatric</strong> <strong>Symptoms</strong> <strong>of</strong> <strong>Epilepsy</strong>, <strong>Neuropsychiatric</strong><br />

<strong>Symptoms</strong> <strong>of</strong> Neurological Disease, DOI 10.1007/978-3-319-22159-5_14<br />

235

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!